Saghir Tabessum

Recent publications · Crossref

5 total works indexed

1. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

   · 2020 · cited 1,172x

2. 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

   · 2018 · cited 951x

3. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

   · 2018 · cited 878x

4. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

   · 2019 · cited 719x

5. The Identification of 2-(1<i>H</i>-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer

   · 2008 · cited 684x

via Crossref · CC0